文献速递区域麻醉与超声术前评估与围术期医学

治疗性肝素输注下安全拔除硬膜外导管的病例报告

Uncomplicated epidural removal in a patient on a therapeutic heparin infusion: a case report.
PubMed 文献 · Reg Anesth Pain Med · 2025-04-10

本文报告一例肝门部胆管癌患者术后发生门静脉完全血栓,需大剂量肝素输注,因暂停抗凝风险极高,经多学科讨论后于最低治疗性抗Xa水平下拔除胸段硬膜外导管,未发生不良事件。

要点

  • 治疗性抗凝下拔除硬膜外导管需多学科权衡出血与血栓风险
  • 本病例在最低治疗性抗Xa水平下拔管并ICU持续监测无不良事件
  • 暂停抗凝可能导致灾难性血栓,需个体化决策

核心结论

  • 多学科讨论对权衡治疗性抗凝下拔除硬膜外导管的血肿风险与暂停抗凝的灾难性血栓风险至关重要。

研究设计与样本

  • 病例报告:一例肝门部胆管癌女性患者,术后留置胸段硬膜外导管,因门静脉完全血栓需大剂量肝素输注。

主要发现

  • 患者术后第1天发生门静脉完全血栓,需急诊开放取栓、经肝支架置入并大剂量肝素输注,同时硬膜外导管在位。
  • 因暂停肝素再血栓风险极高,多学科讨论后选择在不暂停抗凝情况下拔除硬膜外导管。
  • 肝素输注降至最低治疗性抗Xa水平后拔管,ICU持续监测无不良事件。

临床怎么用

  • 对治疗性抗凝患者拔除硬膜外导管,应组织多学科讨论个体化权衡血栓与出血风险。
  • 可考虑在最低治疗性抗Xa水平下拔管,并在ICU持续监测。

局限性

  • 单个病例报告,结果不能推广至所有治疗性抗凝患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unanticipated postoperative thrombotic complications can occur in complex patients who receive preoperative epidurals. Therefore, it is imperative that we consider the risks and benefits of epidural management in the setting of therapeutic anticoagulation. We present a case of epidural catheter removal on a heparin infusion, due to the extreme risk of holding anticoagulation for any duration. CASE REPORT: A woman with hilar cholangiocarcinoma presented after uncomplicated hepatectomy, bile duct resection and hepaticojejunostomy, with a thoracic epidural for analgesia. On postoperative day 1, she developed a total portal vein thrombosis, requiring emergent open thrombectomy, transhepatic stenting and high-dose heparin infusion while the epidural was indwelling. The patient was deemed to have a profound risk of re-thrombosis if heparin were paused. Therefore, a multidisciplinary discussion between hepatobiliary surgery, critical care, neurosurgery, haematology, acute pain service and the patient's family ensued regarding epidural management. Options included catheter-directed thrombolytics to her stent while holding systemic anticoagulation, sterilely leaving the epidural catheter in place indefinitely, injecting prothrombotic agent into the epidural prior to removal, or removing the catheter without holding anticoagulation. Due to the risk of re-thrombosis in the portal vein and liver infarction, the heparin infusion was decreased to achieve the lowest therapeutic anti-Xa level, and the epidural was removed. The patient was continuously monitored in the intensive care unit without any adverse events. CONCLUSION: A multidisciplinary discussion is paramount to weigh the risk of epidural haematoma if a catheter is removed on therapeutic anticoagulation against catastrophic thrombosis if anticoagulation is paused.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Hu L, Adegboye J, Chang AT, et al. Uncomplicated epidural removal in a patient on a therapeutic heparin infusion: a case report. Reg Anesth Pain Med. 2025. PMID: 38821537. doi:10.1136/rapm-2024-105577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。